Potential of tumore suppressor FBXW7 as one of the therapeutic targets
Project/Area Number |
15K10085
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Gunma University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
堤 荘一 群馬大学, 医学部附属病院, 講師 (30323356)
宮崎 達也 群馬大学, 医学部附属病院, 講師 (70372349)
酒井 真 群馬大学, 医学部附属病院, 助教 (70420099)
桑野 博行 群馬大学, 大学院医学系研究科, 教授 (90186560)
緒方 杏一 群馬大学, 医学部附属病院, 助教 (10448897)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | FBXW7 / 消化器癌 / 腹膜播腫 / 胃癌 / HDAC阻害剤 / 腹膜播種 |
Outline of Final Research Achievements |
We previously reported that the expression levels of FBXW7 in gastric cancer tissues were lower than those in non-cancerous tissues. Moreover, the gastric cancer patients with low FBXW7 expression have aggressive phenotypes of gastric cancer and poor prognosis compared to the high expression group. In this study we evaluated the FBXW7 protein expression using IHC. As a result, the low FBXW7 group had tendency of poor prognosis compared to the high expression group. Moreover, the FBXW7 induction by HDAC inhibitor MS-275 was validated in cancer cell lines. The cancer cell lines expressing highly FBXW7 were more sensitive to the anticancer drugs and radiation than control cells The therapeutic strategy to induce the FBXW7 expression by HDAC inhibitors might be a good for refractory gastric cancer patients.
|
Report
(4 results)
Research Products
(10 results)
-
-
[Journal Article] High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer2018
Author(s)
Suzuki K, Watanabe A, Araki K, Yokobori T, Harimoto N, Gantumur D, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Kubo N, Gombodorj N, Nishiyama M, Hosouchi Y, Kuwano H, Shirabe K.
-
Journal Title
Anticancer Research
Volume: 38
Issue: 2
Pages: 939-944
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
[Journal Article] Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study2018
Author(s)
Navchaa Gombodorj, Takehiko Yokobori, Naritaka Tanaka, Shigemasa Suzuki, Kengo Kuriyama, Yuji Kumakura, Tomonori Yoshida, Makoto Sakai, Makoto Sohda, Seded Baatar, Tatsuya Miyazaki, Masahiko Nishiyama, Ken Shirabe, and Hiroyuki Kuwano
-
Journal Title
Journal of Surgical Oncology
Volume: accepted
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
-
[Journal Article] High stathmin 1 expression is associated with poor prognosis and chemoradiation resistance in esophageal squamous cell carcinoma.2017
Author(s)
Shigemasa Suzuki, Takehiko Yokobori, Bolag Altan, Keigo Hara, Daigo Ozawa, Naritaka Tanaka, Makoto Sakai, Akihiko Sano, Makoto Sohda, Halin Bao, Minoru Fukuchi, Tatsuya Miyazaki, Kyoichi Kaira, Takayuki Asao, Hiroyuki Kuwano
-
Journal Title
International Journal of Oncology
Volume: 印刷中
Issue: 4
Pages: 1184-1190
DOI
Related Report
Peer Reviewed
-
[Journal Article] Establishment of a novel method to evaluate peritoneal microdissemination and therapeutic effect using luciferase assay.2016
Author(s)
Takahashi R, Yokobori T, Osone K, Tatsuki H, Takada T, Suto T, Yajima R, Kato T, Fujii T, Tsutsumi S, Kuwano H, Asao T.
-
Journal Title
Cancer Science
Volume: 107(3)
Issue: 3
Pages: 341-346
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant